Support for involvement of glutamate decarboxylase 1 and neuropeptide y in anxiety susceptibility

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 159 B, Issue 3, 2012, Pages 316-327

  Donner, Jonas ^a,b,c   Sipilä, Tessa ^a,b,c   Ripatti, Samuli ^a   Kananen, Laura ^a,b   Chen, Xiangning ^d   Kendler, Kenneth S ^d   Lönnqvist, Jouko ^c,e   Pirkola, Sami ^c,e,f   Hettema, John M ^d   Hovatta, Iiris ^a,b,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f UNIVERSITY OF OULU   (Finland)

Author keywords

Anxiety disorders; Childhood adversities; Gene environment; Genetic association; Phobias

Indexed keywords

GLUTAMATE DECARBOXYLASE; NEUROPEPTIDE Y;

ADULT; ANXIETY DISORDER; ARTICLE; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOBIA; PRIORITY JOURNAL; RISK FACTOR; SELF REPORT; SINGLE NUCLEOTIDE POLYMORPHISM; STRESS;

ADULT; ANXIETY; BASE SEQUENCE; CHILD; CHILD ABUSE; DEMOGRAPHY; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GLUTAMATE DECARBOXYLASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEUROPEPTIDE Y; PHENOTYPE; PHOBIC DISORDERS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84863230375     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32029     Document Type: Article

References (78)

1. Ameli R, Snow J, Rakocevic G, Dalakas MC. 2005. A neuropsychological assessment of phobias in patients with stiff person syndrome. Neurology 64: 1961- 1963.
2. American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association.
3. Amstadter AB, Koenen KC, Ruggiero KJ, Acierno R, Galea S, Kilpatrick DG, Gelernter J. 2009. Variant in RGS2 moderates posttraumatic stress symptoms following potentially traumatic event exposure. J Anxiety Disord 23: 369- 373.
4. Amstadter AB, Koenen KC, Ruggiero KJ, Acierno R, Galea S, Kilpatrick DG, Gelernter J. 2010. NPY moderates the relation between hurricane exposure and generalized anxiety disorder in an epidemiologic sample of hurricane-exposed adults. Depress Anxiety 27: 270- 275.
5. Bale TL, Baram TZ, Brown AS, Goldstein JM, Insel TR, McCarthy MM, Nemeroff CB, Reyes TM, Simerly RB, Susser ES, Nestler EJ. 2010. Early life programming and neurodevelopmental disorders. Biol Psychiatry 68: 314- 319.
6. Bandelow B, Saleh K, Pauls J, Domschke K, Wedekind D, Falkai P. 2010. Insertion/deletion polymorphism in the gene for angiotensin converting enzyme (ACE) in panic disorder: A gender-specific effect? World J Biol Psychiatry 11: 66- 70.
7. Bloch MH, Landeros-Weisenberger A, Sen S, Dombrowski P, Kelmendi B, Coric V, Pittenger C, Leckman JF. 2008. Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: Systematic review. Am J Med Genet Part B 147B: 850- 858.
8. Buckland PR, Hoogendoorn B, Coleman SL, Guy CA, Smith SK, O'Donovan MC. 2005. Strong bias in the location of functional promoter polymorphisms. Hum Mutat 26: 214- 223.
9. Calboli FC, Tozzi F, Galwey NW, Antoniades A, Mooser V, Preisig M, Vollenweider P, Waterworth D, Waeber G, Johnson MR, Muglia P, Balding DJ. 2010. A genome-wide association study of neuroticism in a population-based sample. PLoS One 5: e11504.
10. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R. 2003. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 301: 386- 389.
11. Childs E, Hohoff C, Deckert J, Xu K, Badner J, de Wit H. 2008. Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 33: 2791- 2800.
12. Coric V, Feldman HH, Oren DA, Shekhar A, Pultz J, Dockens RC, Wu X, Gentile KA, Huang SP, Emison E, Delmonte T, D'Souza BB, Zimbroff DL, Grebb JA, Goddard AW, Stock EG. 2010. Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder. Depress Anxiety 27: 417- 425.
13. Costas J, Gratacos M, Escaramis G, Martin-Santos R, de Diego Y, Baca-Garcia E, Canellas F, Estivill X, Guillamat R, Guitart M, Gutierrez-Zotes A, Garcia-Esteve L, Mayoral F, Molto MD, Phillips C, Roca M, Carracedo A, Vilella E, Sanjuan J. 2010. Association study of 44 candidate genes with depressive and anxiety symptoms in post-partum women. J Psychiatr Res 44: 717- 724.
14. Deckert J, Nothen MM, Franke P, Delmo C, Fritze J, Knapp M, Maier W, Beckmann H, Propping P. 1998. Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol Psychiatry 3: 81- 85.
15. Domschke K, Kuhlenbaumer G, Schirmacher A, Lorenzi C, Armengol L, DiBella D, Gratacos M, Garritsen HS, Nothen MM, Franke P, Sand P, Fritze J, Perez G, Maier W, Sibrowski W, Estivill X, Bellodi L, Ringelstein EB, Arolt V, Martin-Santos R, Catalano M, Stogbauer F, Deckert J. 2003. Human nuclear transcription factor gene CREM: Genomic organization, mutation screening, and association analysis in panic disorder. Am J Med Genet Part B 117B: 70- 78.
16. Donner J, Pirkola S, Silander K, Kananen L, Terwilliger JD, Lönnqvist J, Peltonen L, Hovatta I. 2008. An association analysis of murine anxiety genes in humans implicates novel candidate genes for anxiety disorders. Biol Psychiatry 64: 672- 680.
17. Donner J, Haapakoski R, Ezer S, Melen E, Pirkola S, Gratacos M, Zucchelli M, Anedda F, Johansson LE, Soderhall C, Orsmark-Pietras C, Suvisaari J, Martin-Santos R, Torrens M, Silander K, Terwilliger JD, Wickman M, Pershagen G, Lonnqvist J, Peltonen L, Estivill X, D'Amato M, Kere J, Alenius H, Hovatta I. 2010. Assessment of the neuropeptide S system in anxiety disorders. Biol Psychiatry 68: 474- 483.
18. Eaton K, Sallee FR, Sah R. 2007. Relevance of neuropeptide Y (NPY) in psychiatry. Curr Top Med Chem 7: 1645- 1659.
19. Edwards AWF. 1992. Likelihood: Expanded edition. Baltimore, MD: Johns Hopkins University Press.
20. Erhardt A, Lucae S, Kern N, Unschuld PG, Ising M, Lieb R, Uhr M, Hohoff C, Deckert J, Bandelow B, Maier W, Binder EB, Muller-Myhsok B, Keck ME, Holsboer F. 2008. Association of polymorphisms in the angiotensin-converting enzyme gene with syndromal panic attacks. Mol Psychiatry 13: 242- 243.
21. Frustaci A, Pozzi G, Gianfagna F, Manzoli L, Boccia S. 2008. Meta-analysis of the brain-derived neurotrophic factor gene (BDNF) Val66Met polymorphism in anxiety disorders and anxiety-related personality traits. Neuropsychobiology 58: 163- 170.
22. Garakani A, Murrough JW, Charney DS, Bremner D. 2009. The neurobiology of anxiety disorders. In: Charney DS, Nestler EJ, editors. Neurobiology of mental illness. Oxford, New York: Oxford University Press. pp 655- 690.
23. Geis C, Weishaupt A, Grunewald B, Wultsch T, Reif A, Gerlach M, Dirkx R, Solimena M, Perani D, Heckmann M, Toyka KV, Folli F, Sommer C. 2011. Human stiff-person syndrome IgG induces anxious behavior in rats. PLoS One 6: e16775.
24. Gillespie CF, Phifer J, Bradley B, Ressler KJ. 2009. Risk and resilience: Genetic and environmental influences on development of the stress response. Depress Anxiety 26: 984- 992.
25. Green JG, McLaughlin KA, Berglund PA, Gruber MJ, Sampson NA, Zaslavsky AM, Kessler RC. 2010. Childhood adversities and adult psychiatric disorders in the national comorbidity survey replication I: Associations with first onset of DSM-IV disorders. Arch Gen Psychiatry 67: 113- 123.
26. Hall D, Dhilla A, Charalambous A, Gogos JA, Karayiorgou M. 2003. Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am J Hum Genet 73: 370- 376.
27. Hamilton SP. 2009. Linkage and association studies of anxiety disorders. Depress Anxiety 26: 976- 983.
28. Hamilton SP, Slager SL, De Leon AB, Heiman GA, Klein DF, Hodge SE, Weissman MM, Fyer AJ, Knowles JA. 2004a. Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder. Neuropsychopharmacology 29: 558- 565.
29. Hamilton SP, Slager SL, Mayo D, Heiman GA, Klein DF, Hodge SE, Fyer AJ, Weissman MM, Knowles JA. 2004b. Investigation of polymorphisms in the CREM gene in panic disorder. Am J Med Genet Part B 126B: 111- 115.
30. Heistaro S. 2008. Methodology report. Health 2000 survey. Finnish National Public Health Institute.
31. Henningsen P, Meinck HM. 2003. Specific phobia is a frequent non-motor feature in stiff man syndrome. J Neurol Neurosurg Psychiatry 74: 462- 465.
32. Hettema JM, Neale MC, Kendler KS. 2001. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 158: 1568- 1578.
33. Hettema JM, Prescott CA, Myers JM, Neale MC, Kendler KS. 2005. The structure of genetic and environmental risk factors for anxiety disorders in men and women. Arch Gen Psychiatry 62: 182- 189.
34. Hettema JM, An SS, Neale MC, Bukszar J, van den Oord EJ, Kendler KS, Chen X. 2006a. Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism. Mol Psychiatry 11: 752- 762.
35. Hettema JM, Neale MC, Myers JM, Prescott CA, Kendler KS. 2006. A population based twin study of the relationship between neuroticism and internalizing disorders. Am J Psychiatry 163: 857- 864.
36. Hettema JM, An SS, Bukszar J, van den Oord EJ, Neale MC, Kendler KS, Chen X. 2008. Catechol-O-methyltransferase contributes to genetic susceptibility shared among anxiety spectrum phenotypes. Biol Psychiatry 64: 302- 310.
37. Hohoff C, Mullings EL, Heatherley SV, Freitag CM, Neumann LC, Domschke K, Krakowitzky P, Rothermundt M, Keck ME, Erhardt A, Unschuld PG, Jacob C, Fritze J, Bandelow B, Maier W, Holsboer F, Rogers PJ, Deckert J. 2010. Adenosine A(2A) receptor gene: Evidence for association of risk variants with panic disorder and anxious personality. J Psychiatr Res 44: 930- 937.
38. Holmes A, Murphy DL, Crawley JN. 2003. Abnormal behavioral phenotypes of serotonin transporter knockout mice: Parallels with human anxiety and depression. Biol Psychiatry 54: 953- 959.
39. Hovatta I, Barlow C. 2008. Molecular genetics of anxiety in mice and men. Ann Med 40: 92- 109.
40. Itokawa M, Arai M, Kato S, Ogata Y, Furukawa A, Haga S, Ujike H, Sora I, Ikeda K, Yoshikawa T. 2003. Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans. Neurosci Lett 347: 202- 204.
41. Kananen L, Surakka I, Pirkola S, Suvisaari J, Lonnqvist J, Peltonen L, Ripatti S, Hovatta I. 2010. Childhood adversities are associated with shorter telomere length at adult age both in individuals with an anxiety disorder and controls. PLoS One 5: e10826.
42. Kennedy JL, Bradwejn J, Koszycki D, King N, Crowe R, Vincent J, Fourie O. 1999. Investigation of cholecystokinin system genes in panic disorder. Mol Psychiatry 4: 284- 285.
43. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. 2005. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 62: 593- 602.
44. Koenen KC, Amstadter AB, Ruggiero KJ, Acierno R, Galea S, Kilpatrick DG, Gelernter J. 2009. RGS2 and generalized anxiety disorder in an epidemiologic sample of hurricane-exposed adults. Depress Anxiety 26: 309- 315.
45. Leygraf A, Hohoff C, Freitag C, Willis-Owen SA, Krakowitzky P, Fritze J, Franke P, Bandelow B, Fimmers R, Flint J, Deckert J. 2006. Rgs 2 gene polymorphisms as modulators of anxiety in humans? J Neural Transm 113: 1921- 1925.
46. Lindell SG, Schwandt ML, Sun H, Sparenborg JD, Bjork K, Kasckow JW, Sommer WH, Goldman D, Higley JD, Suomi SJ, Heilig M, Barr CS. 2010. Functional NPY variation as a factor in stress resilience and alcohol consumption in rhesus macaques. Arch Gen Psychiatry 67: 423- 431.
47. Maron E, Nikopensius T, Koks S, Altmae S, Heinaste E, Vabrit K, Tammekivi V, Hallast P, Koido K, Kurg A, Metspalu A, Vasar E, Vasar V, Shlik J. 2005. Association study of 90 candidate gene polymorphisms in panic disorder. Psychiatr Genet 15: 17- 24.
48. Maron E, Hettema JM, Shlik J. 2010. Advances in molecular genetics of panic disorder. Mol Psychiatry 15: 681- 701.
49. McLaughlin KA, Green JG, Gruber MJ, Sampson NA, Zaslavsky AM, Kessler RC. 2010. Childhood adversities and adult psychiatric disorders in the national comorbidity survey replication II: Associations with persistence of DSM-IV disorders. Arch Gen Psychiatry 67: 124- 132.
50. Meira-Lima I, Shavitt RG, Miguita K, Ikenaga E, Miguel EC, Vallada H. 2004. Association analysis of the catechol-O-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder. Genes Brain Behav 3: 75- 79.
51. Montag C, Basten U, Stelzel C, Fiebach CJ, Reuter M. 2010. The BDNF Val66Met polymorphism and anxiety: Support for animal knock-in studies from a genetic association study in humans. Psychiatry Res 179: 86- 90.
52. Munafo MR, Durrant C, Lewis G, Flint J. 2009. Gene×environment interactions at the serotonin transporter locus. Biol Psychiatry 65: 211- 219.
53. Nemeroff CB. 2003. The role of GABA in the pathophysiology and treatment of anxiety disorders. Psychopharmacol Bull 37: 133- 146.
54. Olsson M, Annerbrink K, Westberg L, Melke J, Baghaei F, Rosmond R, Holm G, Andersch S, Allgulander C, Eriksson E. 2004. Angiotensin-related genes in patients with panic disorder. Am J Med Genet Part B 127B: 81- 84.
55. Papaleo F, Crawley JN, Song J, Lipska BK, Pickel J, Weinberger DR, Chen J. 2008. Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. J Neurosci 28: 8709- 8723.
56. Pirkola S, Isometsa E, Aro H, Kestila L, Hamalainen J, Veijola J, Kiviruusu O, Lonnqvist J. 2005a. Childhood adversities as risk factors for adult mental disorders: Results from the health 2000 study. Soc Psychiatry Psychiatr Epidemiol 40: 769- 777.
57. Pirkola S, Isometsä E, Suvisaari J, Aro H, Joukamaa M, Poikolainen K, Koskinen S, Aromaa A, Lönnqvist JK. 2005b. DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the finnish general population. Soc Psychiatry Psychiatr Epidemiol 40: 1- 10.
58. Risch N, Herrell R, Lehner T, Liang KY, Eaves L, Hoh J, Griem A, Kovacs M, Ott J, Merikangas KR. 2009. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: A meta-analysis. JAMA 301: 2462- 2471.
59. Rowe DC, Stever C, Gard JM, Cleveland HH, Sanders ML, Abramowitz A, Kozol ST, Mohr JH, Sherman SL, Waldman ID. 1998. The relation of the dopamine transporter gene (DAT1) to symptoms of internalizing disorders in children. Behav Genet 28: 215- 225.
60. Segman RH, Cooper-Kazaz R, Macciardi F, Goltser T, Halfon Y, Dobroborski T, Shalev AY. 2002. Association between the dopamine transporter gene and posttraumatic stress disorder. Mol Psychiatry 7: 903- 907.
61. Shah SH, Freedman NJ, Zhang L, Crosslin DR, Stone DH, Haynes C, Johnson J, Nelson S, Wang L, Connelly JJ, Muehlbauer M, Ginsburg GS, Crossman DC, Jones CJ, Vance J, Sketch MH, Granger CB, Newgard CB, Gregory SG, Goldschmidt-Clermont PJ, Kraus WE, Hauser ER. 2009. Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis. PLoS Genet 5: e1000318.
62. Shifman S, Bhomra A, Smiley S, Wray NR, James MR, Martin NG, Hettema JM, An SS, Neale MC, van den Oord EJ, Kendler KS, Chen X, Boomsma DI, Middeldorp CM, Hottenga JJ, Slagboom PE, Flint J. 2008. A whole genome association study of neuroticism using DNA pooling. Mol Psychiatry 13: 302- 312.
63. Sipilä T, Hovatta I. 2010. Molecular genetics of anxiety. In: Encyclopedia of life sciences (ELS). Chichester: John Wiley & Sons, Ltd.
64. Sipilä T, Kananen L, Greco D, Donner J, Silander K, Terwilliger JD, Auvinen P, Peltonen L, Lonnqvist J, Pirkola S, Partonen T, Hovatta I. 2010. An association analysis of circadian genes in anxiety disorders. Biol Psychiatry 67: 1163- 1170.
65. Smoller JW, Rosenbaum JF, Biederman J, Kennedy J, Dai D, Racette SR, Laird NM, Kagan J, Snidman N, Hirshfeld-Becker D, Tsuang MT, Sklar PB, Slaugenhaupt SA. 2003. Association of a genetic marker at the corticotropin-releasing hormone locus with behavioral inhibition. Biol Psychiatry 54: 1376- 1381.
66. Smoller JW, Yamaki LH, Fagerness JA, Biederman J, Racette S, Laird NM, Kagan J, Snidman N, Faraone SV, Hirshfeld-Becker D, Tsuang MT, Slaugenhaupt SA, Rosenbaum JF, Sklar PB. 2005. The corticotropin-releasing hormone gene and behavioral inhibition in children at risk for panic disorder. Biol Psychiatry 57: 1485- 1492.
67. Smoller JW, Paulus MP, Fagerness JA, Purcell S, Yamaki LH, Hirshfeld-Becker D, Biederman J, Rosenbaum JF, Gelernter J, Stein MB. 2008. Influence of RGS2 on anxiety-related temperament, personality, and brain function. Arch Gen Psychiatry 65: 298- 308.
68. Sommer WH, Lidstrom J, Sun H, Passer D, Eskay R, Parker SC, Witt SH, Zimmermann US, Nieratschker V, Rietschel M, Margulies EH, Palkovits M, Laucht M, Heilig M. 2010. Human NPY promoter variation rs16147:T>C as a moderator of prefrontal NPY gene expression and negative affect. Hum Mutat 31: E1594- E1608.
69. Strug LJ, Suresh R, Fyer AJ, Talati A, Adams PB, Li W, Hodge SE, Gilliam TC, Weissman MM. 2010. Panic disorder is associated with the serotonin transporter gene (SLC6A4) but not the promoter region (5-HTTLPR). Mol Psychiatry 15: 166- 176.
70. Tasan RO, Bukovac A, Peterschmitt YN, Sartori SB, Landgraf R, Singewald N, Sperk G. 2011. Altered GABA transmission in a mouse model of increased trait anxiety. Neuroscience 183: 71- 80.
71. Thorsell A. 2008. Central neuropeptide Y in anxiety- and stress-related behavior and in ethanol intake. Ann N Y Acad Sci 1148: 136- 140.
72. Thorsell A, Michalkiewicz M, Dumont Y, Quirion R, Caberlotto L, Rimondini R, Mathe AA, Heilig M. 2000. Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci USA 97: 12852- 12857.
73. Unschuld PG, Ising M, Erhardt A, Lucae S, Kloiber S, Kohli M, Salyakina D, Welt T, Kern N, Lieb R, Uhr M, Binder EB, Muller-Myhsok B, Holsboer F, Keck ME. 2007. Polymorphisms in the serotonin receptor gene HTR2A are associated with quantitative traits in panic disorder. Am J Med Genet Part B 144B: 424- 429.
74. Wermter AK, Laucht M, Schimmelmann BG, Banaschweski T, Sonuga-Barke EJ, Rietschel M, Becker K. 2010. From nature versus nurture, via nature and nurture, to gene×environment interaction in mental disorders. Eur Child Adolesc Psychiatry 19: 199- 210.
75. Witt SH, Buchmann AF, Blomeyer D, Nieratschker V, Treutlein J, Esser G, Schmidt MH, Bidlingmaier M, Wiedemann K, Rietschel M, Laucht M, Wust S, Zimmermann US. 2011. An interaction between a neuropeptide Y gene polymorphism and early adversity modulates endocrine stress responses. Psychoneuroendocrinology 36: 1010- 1020.
76. Wray NR, James MR, Mah SP, Nelson M, Andrews G, Sullivan PF, Montgomery GW, Birley AJ, Braun A, Martin NG. 2007. Anxiety and comorbid measures associated with PLXNA2. Arch Gen Psychiatry 64: 318- 326.
77. Wray NR, James MR, Gordon SD, Dumenil T, Ryan L, Coventry WL, Statham DJ, Pergadia ML, Madden PA, Heath AC, Montgomery GW, Martin NG. 2009. Accurate, large-scale genotyping of 5HTTLPR and flanking single nucleotide polymorphisms in an association study of depression, anxiety, and personality measures. Biol Psychiatry 66: 468- 476.
78. Zhou Z, Zhu G, Hariri AR, Enoch MA, Scott D, Sinha R, Virkkunen M, Mash DC, Lipsky RH, Hu XZ, Hodgkinson CA, Xu K, Buzas B, Yuan Q, Shen PH, Ferrell RE, Manuck SB, Brown SM, Hauger RL, Stohler CS, Zubieta JK, Goldman D. 2008. Genetic variation in human NPY expression affects stress response and emotion. Nature 452: 997- 1001.